Following TYBR’s B3 GEL’s US launch in January 2026, the company primarily intends to use the funds to expand market access to the hydrogel.
Health technology brand Hilo, developed by Aktiia, has launched its Hilo Core blood pressure monitoring system in the US.
Cardinal Health’s acquisitions of Strive Medical and Adapt Health’s diabetes unit are collectively intended to support its at-home care business’s growth strategy.
Fresenius Medical Care has introduced TherapyWise, a cloud-based analytics platform aimed at supporting hospital and critical care teams overseeing KRT in the US.